The Department of Health and Social Care has published the quarter three (October-December 2020) category M prices. The effect of the adjustment is to reduce medicine margin downwards by £23.3 million per quarter (£7.77 million per month).
In summary in the third quarter, there are:
- 493 prices have fallen, 28 by at least 25 per cent
- 141 prices have risen, six by more than 50 per cent
- Two additions and two deletions
|Bimatoprost 100micrograms/ml eye drops||3|
|Tamsulosin 400microgram / Dutasteride 500microgram capsules||30|
|Diamorphine 10mg powder for solution for injection ampoules||5|
|Nizatidine 150mg capsules||30|
The five biggest % price reductions are:
|Hydrocortisone 1% cream||30||3.12||-39%|
|Hydrocortisone 1% cream||50||5.2||-39%|
|Tizanidine 2mg tablets||120||14.03||-41%|
|Rizatriptan 10mg orodispersible tablets sugar free||3||3.05||-41%|
|Vardenafil 20mg tablets||4||8.2||-53%|
The five biggest % price increases are:
|Co-fluampicil 250mg/250mg capsules||28||18.18||466%|
|Sertraline 100mg tablets||28||5.89||196%|
|Valaciclovir 500mg tablets||10||24.11||190%|
|Sertraline 50mg tablets||28||4.22||172%|
|Exemestane 25mg tablets||30||20.98||145%|
DDA members can view the full spreadsheet with history, sorted by price, price increase, and percentage price increase by visiting the online library of Category M updates.
Further information on the adjustment is available from PSNC.